Company Filing History:
Years Active: 2016
Title: Mark R Contarino: Innovator in HIV-1 Research
Introduction
Mark R Contarino is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medical research, particularly in the area of HIV-1 treatment. His innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Mark R Contarino holds a patent for "Compositions for promoting HIV-1 virolysis and methods using same." This invention includes compounds that are useful for treating or preventing an HIV-1 infection in a mammal. In certain embodiments, the compounds cause cell-free virolysis of an HIV-1 virus. The presented invention further includes a method of causing virolysis of a virus using the compounds described therein. Additionally, it outlines a method of treating or preventing an HIV-1 infection in a mammal in need thereof using the compositions described.
Career Highlights
Mark R Contarino is affiliated with Drexel University, where he continues to engage in groundbreaking research. His work is pivotal in advancing the understanding and treatment of HIV-1, contributing to the broader field of virology and infectious diseases.
Collaborations
Some of his notable coworkers include Cameron Frank Abrams and Irwin M Chaiken. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.
Conclusion
Mark R Contarino's contributions to HIV-1 research exemplify the impact of innovative thinking in addressing global health issues. His patent reflects a commitment to improving treatment options for those affected by this virus.